dihydrotestosterone has been researched along with Cardiovascular Diseases in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.00) | 18.7374 |
1990's | 3 (12.00) | 18.2507 |
2000's | 2 (8.00) | 29.6817 |
2010's | 16 (64.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Biggs, ML; Gottdiener, JS; Hirsch, CH; Kizer, JR; Matsumoto, AM; Mukamal, KJ; Njoroge, JN; Rosenberg, E; Smith, NL; Tressel, W | 1 |
Bornfeldt, KE; Chandran, A; Dorfman, MD; Fasnacht, RD; Frey, JM; Kanter, JE; Lala, E; Meek, TH; Melhorn, SJ; Monfeuga, T; Rubinow, KB; Schur, EA; Thaler, JP; Velasco, I | 1 |
Adams, RJ; Antonio, L; Ballantyne, CM; Bhasin, S; Cawthon, PM; Couper, DJ; Dobs, AS; Flicker, L; Karlsson, M; Marriott, RJ; Martin, SA; Matsumoto, AM; Mellström, D; Murray, K; Norman, PE; O'Neill, TW; Ohlsson, C; Orwoll, ES; Shores, MM; Travison, TG; Vanderschueren, D; Wittert, GA; Wu, FCW; Yeap, BB | 1 |
Chan, YX; Chasland, LC; Divitini, ML; Green, DJ; Handelsman, DJ; Knuiman, MW; Naylor, LH; Yeap, BB | 1 |
Almeida, OP; Chasland, LC; Divitini, ML; Flicker, L; Golledge, J; Green, DJ; Handelsman, DJ; Hankey, GJ; Knuiman, MW; Murray, K; Naylor, LH; Ridgers, ND; Yeap, BB | 1 |
Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO | 1 |
Arnold, AM; Biggs, ML; Cappola, AR; Hirsch, CH; Kizer, JR; Longstreth, WT; Matsumoto, AM; Shores, MM; Smith, NL | 1 |
Borst, SE; Jia, H; Shuster, JJ; Wokhlu, A; Yarrow, JF; Ye, F; Zou, B | 1 |
Beilin, J; Divitini, ML; Handelsman, DJ; Hunter, M; James, AL; Knuiman, MW; Mohan, SS; Musk, AW; Yeap, BB | 1 |
Beilby, JP; Beilin, J; Chan, YX; Divitini, ML; Handelsman, DJ; Hung, J; Knuiman, MW; McQuillan, B; Yeap, BB | 1 |
Biggs, ML; Djoussé, L; Ix, JH; Joyce, KE; Kizer, JR; Matsumoto, AM; Mukamal, KJ; Shores, MM; Siscovick, DS | 1 |
Romero, DG; Yanes, LL | 1 |
Bao, S; Celermajer, DS; Chow, RW; Dunn, LL; Handelsman, DJ; Heather, AK; Lim, P; McGrath, KC; Ng, MK; Sieveking, DP | 1 |
Magee, PJ | 1 |
Dušková, M; Pospíšilová, H | 1 |
Schmidt, C | 1 |
Davis, DD; Lima, R; Lockhart, R; Moulana, M; Racusen, LC; Reckelhoff, JF; Romero, DG; Yanes, LL; Zhang, H | 1 |
Amory, JK; Page, ST; Rubinow, KB | 1 |
Soory, M; Tilakaratne, A | 1 |
Antal, P; Masszi, G; Monori-Kiss, A; Monos, E; Nadasy, GL; Sara, L; Szekeres, M; Varbiro, S | 1 |
Björntorp, P; Elander, A; Eldh, J; Gustafsson, C; Holm, G; Holmäng, S; Jönsson, L; Kvist, H; Mårin, P; Sjöström, L | 1 |
Lombard, JH; Roman, RJ | 1 |
de Lignieres, B | 1 |
Gruber, DM; Huber, JC | 1 |
Guberan, E | 1 |
5 review(s) available for dihydrotestosterone and Cardiovascular Diseases
Article | Year |
---|---|
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.
Topics: Administration, Cutaneous; Adult; Cardiovascular Diseases; Dihydrotestosterone; Hormone Replacement Therapy; Humans; Injections, Intramuscular; Male; Randomized Controlled Trials as Topic; Risk Factors; Testosterone | 2014 |
The role of non-aromatizable testosterone metabolite in metabolic pathways.
Topics: Adipose Tissue; Alopecia; Androgens; Animals; Body Composition; Cardiovascular Diseases; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Mice; Obesity; Prostatic Hyperplasia; Rats; Receptors, Androgen; Testosterone | 2011 |
Does 20-hydroxyeicosatetraenoic acid contribute to sex differences in cardiovascular risk by increasing oxidative stress?
Topics: Animals; Cardiovascular Diseases; Dihydrotestosterone; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Oxidative Stress; Risk Factors; Sex Characteristics | 2007 |
Transdermal dihydrotestosterone treatment of 'andropause'.
Topics: Administration, Cutaneous; Aged; Aging; Cardiovascular Diseases; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 1993 |
Conjugated estrogens--the natural SERMs.
Topics: 2-Methoxyestradiol; Anticarcinogenic Agents; Cardiovascular Diseases; Dihydrotestosterone; Equilin; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxyestrones; Osteoporosis; Progesterone; Selective Estrogen Receptor Modulators; Testosterone; Thyroxine; Triiodothyronine | 1999 |
2 trial(s) available for dihydrotestosterone and Cardiovascular Diseases
Article | Year |
---|---|
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult | 2019 |
Androgen treatment of abdominally obese men.
Topics: Abdominal Fat; Adult; Aged; Androgens; Blood Glucose; Blood Pressure; Body Composition; Body Weight; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dihydrotestosterone; Double-Blind Method; Glucose; Gonadotropins; Humans; Lipid Metabolism; Male; Middle Aged; Obesity; Placebos; Prostate-Specific Antigen; Risk Factors; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Tomography, X-Ray Computed; Triglycerides | 1993 |
18 other study(ies) available for dihydrotestosterone and Cardiovascular Diseases
Article | Year |
---|---|
Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study.
Topics: Aged; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Estradiol; Heart Failure; Humans; Male; Sex Hormone-Binding Globulin; Testosterone | 2022 |
Central androgen action reverses hypothalamic astrogliosis and atherogenic risk factors induced by orchiectomy and high-fat diet feeding in male mice.
Topics: Androgens; Animals; Cardiovascular Diseases; Cross-Sectional Studies; Diet, High-Fat; Dihydrotestosterone; Gliosis; Humans; Male; Mice; Orchiectomy; Proprotein Convertase 9; Risk Factors | 2023 |
Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men.
Topics: Adult; Androgens; Cardiovascular Diseases; Cause of Death; Cohort Studies; Dementia; Dihydrotestosterone; Estradiol; Humans; Incidence; Logistic Models; Male; Mass Spectrometry; Men's Health; Meta-Analysis as Topic; Neoplasms; Prospective Studies; Testosterone | 2020 |
Greater physical activity and higher androgen concentrations are independently associated with lower cardiometabolic risk in men.
Topics: Androgens; Cardiovascular Diseases; Dihydrotestosterone; Estradiol; Exercise; Humans; Male; Middle Aged; Risk Assessment; Testosterone | 2017 |
Higher circulating androgens and higher physical activity levels are associated with less central adiposity and lower risk of cardiovascular death in older men.
Topics: Adiposity; Adult; Aged; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Estradiol; Exercise; Follow-Up Studies; Humans; Male; Middle Aged; Obesity, Abdominal; Risk; Testosterone | 2019 |
Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Dihydrotestosterone; Humans; Incidence; Longitudinal Studies; Male; Mortality; Residence Characteristics; Risk Factors; Testosterone | 2014 |
Higher serum testosterone and dihydrotestosterone, but not oestradiol, are independently associated with favourable indices of lung function in community-dwelling men.
Topics: Adult; Aged; Androgens; Asthma; Body Mass Index; Cardiovascular Diseases; Dihydrotestosterone; Estradiol; Forced Expiratory Volume; Humans; Linear Models; Lung; Male; Mass Spectrometry; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Risk Factors; Smoking; Spirometry; Testosterone; Vital Capacity; Western Australia | 2015 |
Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Dihydrotestosterone; Estradiol; Follow-Up Studies; Humans; Male; Mass Spectrometry; Middle Aged; Testosterone; Young Adult | 2016 |
Testosterone, Dihydrotestosterone, Sex Hormone-Binding Globulin, and Incident Diabetes Among Older Men: The Cardiovascular Health Study.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Dihydrotestosterone; Follow-Up Studies; Humans; Incidence; Insulin Resistance; Longitudinal Studies; Male; Middle Aged; Prognosis; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2017 |
Dihydrotestosterone stimulates aldosterone secretion by H295R human adrenocortical cells.
Topics: Adrenal Cortex; Aldosterone; Calcium-Calmodulin-Dependent Protein Kinases; Cardiovascular Diseases; Cell Line; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Humans; Male; Protein Kinase C; Sex Factors; Signal Transduction | 2009 |
A sex-specific role for androgens in angiogenesis.
Topics: Androgen Receptor Antagonists; Animals; Cardiovascular Diseases; Castration; Dihydrotestosterone; Endothelial Cells; Female; Hindlimb; Humans; Ischemia; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Receptors, Androgen; Recovery of Function; Sex Factors | 2010 |
Is equol production beneficial to health?
Topics: Antioxidants; Bone Diseases; Cardiovascular Diseases; Dihydrotestosterone; Equol; Glycine max; Hot Flashes; Humans; Intestinal Mucosa; Intestines; Isoflavones; Neoplasms; Phenotype; Phytoestrogens; Phytotherapy; Plant Extracts; Receptors, Estrogen; Risk Factors | 2011 |
Abiraterone and MVD3100 take androgen deprivation to a new level.
Topics: Androgen Antagonists; Androstenes; Androstenols; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Diabetes Mellitus; Dihydrotestosterone; Drug Approval; Gonadotropin-Releasing Hormone; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone; Time Factors; United States; United States Food and Drug Administration | 2011 |
Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.
Topics: Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Dihydrotestosterone; Disease Models, Animal; Estradiol; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Kidney Diseases; Leptin; Metabolic Syndrome; Oxidative Stress; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2011 |
Androgens exert sexually dimorphic effects on angiogenesis: novel insight into the relationship between androgens and cardiovascular disease.
Topics: Androgens; Animals; Cardiovascular Diseases; Dihydrotestosterone; Humans; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Stem Cells; Testosterone | 2011 |
Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases.
Topics: Androstenedione; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Chromatography, Thin Layer; Dihydrotestosterone; Gas Chromatography-Mass Spectrometry; Glucose; Humans; Lipopolysaccharides; Lipoproteins, LDL; Metabolic Diseases; Minocycline; Osteoblasts; Oxidation-Reduction; Oxidative Stress; Periodontal Diseases; Testosterone; Time Factors; Wound Healing | 2012 |
Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D₃ treatment.
Topics: Animals; Arterioles; Cardiovascular Agents; Cardiovascular Diseases; Cholecalciferol; Dihydrotestosterone; Disease Models, Animal; Drug Implants; Endothelium, Vascular; Female; Injections, Subcutaneous; Muscle, Skeletal; Muscle, Smooth, Vascular; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Thigh; Vascular Resistance; Vasoconstriction; Vasodilation | 2012 |
Surprising decline of cardiovascular mortality in Switzerland: 1951-1976.
Topics: Cardiovascular Diseases; Contraceptives, Oral; Dihydrotestosterone; Feeding Behavior; Female; Humans; Hypertension; Male; Rheumatic Heart Disease; Sex Factors; Smoking; Switzerland; Testosterone | 1979 |